- •Symptoms of irritable bowel syndrome (IBS) are common reasons for endoscopic procedures.
- •We examined the yield of colonoscopy and upper endoscopy in IBS in a large cohort.
- •Inflammatory bowel disease, precancerous polyps, colorectal cancer, and celiac disease were all less common in IBS compared to controls.
- •Microscopic colitis was more common in IBS patients.
- •The yield of upper endoscopy and colonoscopy for organic disease is low in patients with a first-time diagnosis of IBS.
Abbreviations:CI (confidence interval), OR (Odds ratio), IBD (inflammatory bowel disease), IBS (irritable bowel syndrome)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.Clin Gastroenterol Hepatol. 2012; 10 (e4): 712-721
- Mortality risk in irritable bowel syndrome: results from a nationwide prospective cohort study.Am J Gastroenterol. 2020;
- Clinical economics review: irritable bowel syndrome.Aliment Pharmacol Ther. 1997; 11: 1019-1030
- Costs of care for irritable bowel syndrome patients in a health maintenance organization.Am J Gastroenterol. 2001; 96: 3122-3129
- Colonoscopy utilization and outcomes 2000 to 2011.Gastrointest Endosc. 2014; 80: 133-143
- Review article: the economic impact of the irritable bowel syndrome.Aliment Pharmacol Ther. 2014; 40: 1023-1034
- The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.Am J Gastroenterol. 2010; 105: 859-865
- Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.Scand J Gastroenterol. 2015; 50: 816-823
- Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case–control study.Int J Colorectal Dis. 2011; 26: 935-940
- Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan.Br J Cancer. 2015; 112: 171-176
- Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders.Aliment Pharmacol Ther. 2016; 43: 851-862
- Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome.Scand J Gastroenterol. 2017; 52: 173-177
- Irritable bowel syndrome and microscopic colitis: a systematic review and meta-analysis.Clin Gastroenterol Hepatol. 2016; 14 (e1quiz e54-5): 659-668
- Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis.Am J Gastroenterol. 2017; 112: 65-76
- A primary care cross-sectional study of undiagnosed adult coeliac disease.Eur J Gastroenterol Hepatol. 2003; 15: 407-413
- Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden).Clin Epidemiol. 2019; 11: 101-114
- Validating microscopic colitis (MC) in Swedish pathology registers.Scand J Gastroenterol. 2018; 53: 1469-1475
- Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers.BMC Gastroenterol. 2009; 9: 19
- Antibiotic use and the development of inflammatory bowel disease: a national case/control study in Sweden.Lancet Gastroenterol Hepatol. 2020;
- Validation of serrated polyps (SPs) in Swedish pathology registers.BMC Gastroenterol. 2019; 20: 3
- Registers of the Swedish total population and their use in medical research.Eur J Epidemiol. 2016; 31: 125-136
- Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research.Eur J Epidemiol. 2019; 34: 423-437
- External review and validation of the Swedish national inpatient register.BMC Public Health. 2011; 11: 450
- Validation of the Use of the ICD-10 Diagnostic Code for Irritable Bowel Syndrome in the Swedish National Patient Register.Gastroenterology. 2014; 146: S543
- Colorectal Cancer Incidence Patterns in the United States, 1974-2013.J Natl Cancer Inst. 2017; 109
- Ethical aspects of registry-based research in the Nordic countries.Clin Epidemiol. 2015; 7: 491-508
- Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.Clin Ther. 2006; 28 (discussion 10-1): 1726-1735
- Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study.Eur J Intern Med. 2014; 25: 82-86
- Risk of cancer in patients with irritable bowel syndrome: a nationwide population-based study.Ann Epidemiol. 2015; 25: 924-928
- Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study.Br J Cancer. 2011; 104: 1202-1206
- A randomly selected population sample undergoing colonoscopy: prevalence of the irritable bowel syndrome and the impact of selection factors.Eur J Gastroenterol Hepatol. 2014; 26: 268-275
- The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls.Gastroenterology. 2011; 141: 1187-1193
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research.Eur J Epidemiol. 2009; 24: 659-667
- The epidemiology of irritable bowel syndrome.Clin Epidemiol. 2014; 6: 71-80